Updated statement by the German Society for Pediatric and Adolescent Rheumatology (GKJR) on the FDA’s report regarding malignancies in anti-TNF-treated patients from Aug 4, 2009 - Horneff, G; Hospach, T; Dannecker, G (Z Rheumatol, 2010)
et al.